glp 1 drugs and cancer GLP-1 may be linked to a lower risk of progression, according to new research that will be presented next week at the American Society of Clinical Oncology's annual meeting GLP-1 drugs may have a

Medicaid costs roughly quadrupled between the start of fiscal year 2024 and the end of fiscal year 2025 in per-member monthly payments to Medicaid managed care plans, according to the states Executive Office of Health and Human Services, which administers Rhode Islands Medicaid program

By targeting both of these receptors, tirzepatide offers a dual mechanism of action that enhances its effectiveness in managing both blood sugar levels and body weight

This piece in 1993 also provided new insights into the biology of exendin, namely that exendin-4 was a full agonist of the human GLP-1 receptor, which Mojsov argues was crucial to convincing Amylin to develop exendin as a drug for diabetes (see below)

The study, led by Raphael Cuomo, Ph.D., associate professor in the Department of Anesthesiology at UC San Diego School of Medicine and member of UC San Diego Moores Cancer Center, used real-world clinical data from the University of California Health Data Warehouse to assess outcomes across the states academic medical centers

Mishra R et al

Perry, T